Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDLantern Pharma Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.55 | -$0.55 | -$0.55 |
| Q2 2024 | 1 | -$0.56 | -$0.56 | -$0.56 |
| Q3 2024 | 1 | -$0.51 | -$0.51 | -$0.51 |
Lantern Pharma Inc. Earnings Date And Information
Lantern Pharma Inc. last posted its earnings results on Thursday, November 7th, 2024. The company reported $-0.42 earnings per share for the quarter, topping analysts' consensus estimates of $-0.56 by $0.14. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Lantern Pharma Inc. has generated $-1 earnings per share over the last year ($-1.47 diluted earnings per share) and currently has a price-to-earnings ratio of -1.76. Lantern Pharma Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 17th, 2025 based on prior year's report dates.
Lantern Pharma Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/07/2024 | Q3 2024 | -$0.56 | -$0.42 | 0.14 | $0 | $0 |
| 08/08/2024 | Q2 2024 | -$0.55 | -$0.46 | 0.09 | $0 | $0 |
| 05/09/2024 | Q1 2024 | -$0.43 | -$0.51 | -0.08 | $0 | |
| 03/18/2024 | Q4 2023 | -$0.40 | -$0.39 | 0.01 | $261,052 | |
| 11/08/2023 | Q3 2023 | -$0.46 | -$0.29 | 0.17 | $0 | |
| 08/09/2023 | Q2 2023 | -$0.40 | -$0.44 | -0.04 | $0 | |
| 05/09/2023 | Q1 2023 | -$0.48 | -$0.32 | 0.16 | $0 | |
| 03/20/2023 | Q4 2022 | -$0.49 | -$0.27 | 0.22 | $0 | |
| 11/07/2022 | Q3 2022 | -$0.54 | -$0.22 | 0.32 | $0 | |
| 08/08/2022 | Q2 2022 | -$0.52 | -$0.42 | 0.1 | $0 | |
| 05/03/2022 | Q1 2022 | -$0.29 | -$0.38 | -0.09 | $0 | |
| 03/10/2022 | Q4 2021 | -$0.40 | -$0.32 | 0.08 | $0 | |
| 11/01/2021 | Q3 2021 | -$0.27 | -$0.36 | -0.09 | $0 | |
| 07/29/2021 | Q2 2021 | -$0.26 | -$0.21 | 0.05 | $0 | |
| 05/03/2021 | Q1 2021 | -$0.26 | -$0.24 | 0.02 | $0 | |
| 03/10/2021 | Q4 2020 | -$0.47 | -$0.47 | 0 | $0 | |
| 10/29/2020 | Q3 2020 | -$0.33 | -$0.27 | 0.06 | $0 | |
| 07/30/2020 | Q2 2020 | -$0.37 | -$0.31 | 0.06 | $0 | |
| 03/30/2020 | Q1 2020 | -$0.08 | $0 | |||
| 12/30/2019 | Q4 2019 | -$0.11 | $0 |
Lantern Pharma Inc. Earnings: FAQ's
When is Lantern Pharma Inc.'s earnings date?
Lantern Pharma Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 17th, 2025 based off last year's report dates.
Did Lantern Pharma Inc. beat their earnings estimates last
quarter?
In the previous quarter, Lantern Pharma Inc. (:LTRN) reported $-0.42 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.56 by $0.14.
How can I listen to Lantern Pharma Inc.'s earnings conference
call?
The conference call for Lantern Pharma Inc.'s latest earnings report can be listened to online.
How can I read Lantern Pharma Inc.'s conference call transcript?
The conference call transcript for Lantern Pharma Inc.'s latest earnings report can be read online.
How much profit does Lantern Pharma Inc. generate each year?
Lantern Pharma Inc. (:LTRN) has a recorded net income of $0. Lantern Pharma Inc. has generated $-1.47 earnings per share over the last four quarters.
What is Lantern Pharma Inc.'s price-to-earnings ratio?
Lantern Pharma Inc. (:LTRN) has a price-to-earnings ratio of -1.76 and price/earnings-to-growth ratio is 0.22.